Given that our work showed the potential linking between RIPK2 dysregulated expression and altered immunological activities in the tumor microenvironment of KIRC, we believe that the increase of RIPK2 transcripts would cause NF-κB signaling activation and subsequently contributing to KIRC pathogenesis and aggressiveness. The gene discussed is NFKB1; the disease is neoplasm.